Clinical Trial Update: Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial [Phase 3]

View source ↗

Summary

The PROBE trial is a Phase 3 study evaluating immunotherapy-based combination therapy for metastatic renal cell carcinoma with or without surgical removal of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 3 | Status: RECRUITING